News and Announcements
Read the latest news from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. The links below take you to articles where you can learn more about our center's latest events and accomplishments. You can also visit the article archive for older news.
A drug called palbociclib, used in combination with standard treatment, improved survival for women with hormone receptor-positive metastatic breast cancer.
Targeting cancer cells with a transcription elongation inhibitor delayed tumor progression in animal models, according to a recent Northwestern Medicine study.
In a recent clinical trial, a drug called apalutamide added to standard therapy slowed cancer progression in men with prostate cancer, while maintaining quality of life.
Teresa K. Woodruff, vice chair for research in the department of obstetrics and gynecology at Northwestern University Feinberg School of Medicine, has been elected to the National Academy of Medicine, an independent organization of professionals from the fields of health and medicine and natural, social and behavioral sciences.
Arthur Prindle, PhD, assistant professor of Biochemistry and Molecular Genetics, has been named a 2018 Packard Fellow, one of 18 scientists across the globe recognized for their pursuit of scientific discovery.
Zibo Zhao, PhD, a postdoctoral fellow in the laboratory of Ali Shilatifard, PhD, has received a 2018 Young Investigator Grant from Alex’s Lemonade Stand Foundation (ALSF) to further her research focused on developing new therapies for children with leukemia.
Roughly one in eight American women will develop invasive breast cancer in her lifetime. And so, in a way, will her family and friends. Though the diagnosis of any illness—or even the news of increased risk—inevitably has an impact on a patient’s relationships, the fallout is perhaps never more varied and unpredictable than with breast cancer.
Melissa Simon, MD, MPH, will receive the 2018 Award for Excellence from the American Public Health Association (APHA). Simon is the George H. Gardner Professor of Clinical Gynecology, co- leader of the Cancer Control and Survivorship Research Program at the Lurie Cancer Center, vice chair for clinical research in the Department of Obstetrics and Gynecology, and director of the new Center for Health Equity Transformation in the Feinberg School of Medicine.
Advances in subtype-specific treatments, immunotherapy, ongoing issues with younger patients, the optimal use of neoadjuvant and adjuvant regimens, and molecular testing will all be at the forefront of discussion during the 20th Annual Lynn Sage Breast Cancer Symposium.
Northwestern Medicine investigators are leading a Specialized Program of Research Excellence (SPORE) in brain cancer with a special emphasis on glioblastoma.
National Cancer Institute Director, Norman “Ned” Sharpless, MD, visited the Robert H. Lurie Comprehensive Cancer Center of Northwestern University on October 2, one year after becoming the 15th director of the nation’s principal agency for cancer research and training, and the world’s largest funder of cancer research.
A new study has identified genes that, when inhibited, may slow or stop the progression of primary effusion lymphoma.
Since 2016, when Jill Haagenson learned that her breast cancer had spread to her brain, Jill has seen oncologists from five different hospitals in three different states, including Priya Kumthekar, MD, director of the brain metastases program at the Northwestern Medicine Lou and Jean Malnati Brain Tumor Institute of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital.
As a nurse practitioner in the Division of Immunotherapy and Autoimmune Disease at Northwestern Memorial Hospital, Michelle Calvario, MS, APRN-CNP, AGACNP-BC, has a unique perspective to share with her patients and their family members because she has been in their shoes — twice.
What we eat, how much we exercise, where we live and how we handle stress — Lifang Hou, MD, PhD, says these are just some of the variables that interact with our genes in cancer development. And she intends to prove it.
Faculty, family and friends gathered at a symposium to honor Robert Goldman, PhD, chair of Cell and Molecular Biology, and his distinguished scientific career.
On September 27, Lurie Cancer Center hosted the seventh annual Chung Lee Lecture, held to honor Chung Lee, PhD, professor emeritus in the Department of Urology at the Feinberg School of Medicine.
A novel chemotherapy regimen led to improved outcomes for older patients with Hodgkin lymphoma, similar to those of younger patients, according to a Northwestern Medicine clinical trial.
Led by Melissa Simon, MD, MPH, the Center for Health Equity Transformation will build research infrastructure, conduct workforce development and support community partners in the effort to advance population health equity.
A protein facilitating DNA replication during cell cycle also binds microtubules, findings that could inform more effective cancer treatments, according to a recent study published in the Journal of Cell Biology.
See more news in the article archive.